Stanford Health Care Specialty Pharmacy

Validation Systems is a full service validation contractor and laboratory service provider. It has been servicing the pharmaceutical, biotechnology and medical device industries since 1990. VSI is owned and operated by validation professionals. Its management team consists of individuals with diverse backgrounds. The company offers all levels of validation support from start to finish large-scale projects to small individual projects. VSI s team consists of individuals with a broad range of experience and expertise that allows it to work on a wide variety of projects. VSI was established in 1990 and has expanded its services and gained experience working with a wide range of projects with a diverse group of clients. The first VSI office was opened in 1990 in Santa Clara, Calif., in the heart of the biotechnology and high tech industries of Silicon Valley. Corporate headquarters is located in Palo Alto, Calif.

Alexza Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The company's technology, the Staccato system, vaporizes unformulated drug compound to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. Alexza Pharmaceuticals has four product candidates in clinical development: AZ-001 (Staccato prochlorperazine) for the treatment of acute migraine headaches; AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder; AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia; and AZ-003 (Staccato fentanyl) for the treatment of patients with acute pain. Alexza Pharmaceuticals is located in Palo Alto, Calif.